9:30 Driving Precision Medicine in Neurology Through Biomarker-Driven Development

• Exploring biomarker strategies across neurodegenerative therapeutic programs, including Alzheimer’s and rare diseases
• Insights into the application of targeted antibody therapies in advancing clinical development strategies

Speakers:

Holly Soares

Global Vice president & Head of Neuroscience & Rare Disease Biomarkers

Roche